Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

6.29
-0.5450-7.97%
Post-market: 6.380.0900+1.43%19:59 EDT
Volume:8.36M
Turnover:53.59M
Market Cap:365.69M
PE:-2.55
High:7.08
Open:6.81
Low:6.01
Close:6.84
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:45.54M
Volume Ratio:0.38
T/O Rate:18.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:1.49
PE(LYR):-2.78

Loading ...

Capricor director Karimah Es Sabar disposes of $0.2 million common shares

Reuters
·
Apr 04

Capricor director Karimah Es Sabar disposes of common shares worth $3.5 million

Reuters
·
Apr 02

Capricor EVP, General Counsel Karen Krasney disposes of CAPR shares worth $0.8 million

Reuters
·
Apr 02

Capricor CFO Anthony Bergmann disposes of $0.8 million in common shares

Reuters
·
Apr 02

Capricor Therapeutics announces annual shareholder meeting, issues proxy statement

Reuters
·
Apr 01

Roth MKM Keeps Their Buy Rating on Capricor Therapeutics (CAPR)

TIPRANKS
·
Mar 20

Capricor Therapeutics Nears Key Milestones After Earnings Call

TIPRANKS
·
Mar 14

Capricor selloff today a buying opportunity, says Roth Capital

TIPRANKS
·
Mar 14

Alliance Global Partners Keeps Their Buy Rating on Capricor Therapeutics (CAPR)

TIPRANKS
·
Mar 14

Capricor Therapeutics Inc : B. Riley Raises Target Price to $63 From $50

THOMSON REUTERS
·
Mar 13

B. Riley Adjusts Price Target on Capricor Therapeutics to $63 From $50, Maintains Buy Rating

MT Newswires Live
·
Mar 13

Capricor Therapeutics Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 13

Capricor Therapeutics Q4 Loss Widens

MT Newswires Live
·
Mar 13

Earnings Flash (CAPR) Capricor Therapeutics Posts Q4 Loss $-0.62, vs. FactSet Est of Loss of $-0.55

MT Newswires Live
·
Mar 13

Capricor announces additional analyses, outcomes from Phase 3 HOPE-3 trial

TIPRANKS
·
Mar 12

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

GlobeNewswire
·
Mar 12

Roth MKM Remains a Buy on Capricor Therapeutics (CAPR)

TIPRANKS
·
Mar 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 11

Capricor Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview

Reuters
·
Mar 11

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

MT Newswires Live
·
Mar 11